Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tribendimidine for clonorchiasis in adults in China
ISRCTN80829842Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Mar 2012
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of tribendimidine and praziquantel in clonorchiasis (3 arms), sponsored by Medical Research Council. Primary endpoints: Cure rate and Egg reduction rate. Started Mar 2012; status: completed.
02
Drugs
tribendimidinepraziquantel
03
Conditions
clonorchiasis
Beyond the preview
Go deeper on ISRCTN80829842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN80829842.